EQS-News: Epigenomics AG / Key word(s): Miscellaneous/Restructure of Company Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations) 10.03.2023 / 09:37 CET/CEST The issuer is solely responsible for the content of this announcement. Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated […]
Category: Press Releases
10. March 2023
Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)
Read more
15. February 2023
Epigenomics resolves on restructuring to minimize costs
Epigenomics AG / Key word(s): Restructure of Company/Financing Epigenomics resolves on restructuring to minimize costs 15-Feb-2023 / 11:13 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content of […]
15. February 2023
Epigenomics decides to restructure to minimize costs
EQS-News: Epigenomics AG / Key word(s): Restructure of Company/FinancingEpigenomics decides to restructure to minimize costs 15.02.2023 / 11:18 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics decides to restructure to minimize costs Berlin (Germany) and San Diego, CA (U.S.A.) February 15, 2023 – The Executive Board of Epigenomics AG (Frankfurt Prime […]
27. January 2023
Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski 27.01.2023 / 18:08 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski Berlin (Germany), January 27, 2023 -The Chairman of the Supervisory Board of Epigenomics AG (Frankfurt […]
23. December 2022
Pareto Securities AS publishes buy recommendation for Epigenomics AG share
EQS-News: Epigenomics AG / Key word(s): Research Update/Study resultsPareto Securities AS publishes buy recommendation for Epigenomics AG share 23.12.2022 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Pareto Securities AS publishes buy recommendation for Epigenomics AG share Berlin (Germany), December 23, 2022 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: […]
14. December 2022
Epigenomics Releases Performance Data on Next Generation Test
EQS-News: Epigenomics AG / Key word(s): Study results/MiscellaneousEpigenomics Releases Performance Data on Next Generation Test 14.12.2022 / 05:23 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics Releases Performance Data on Next Generation Test Epigenomics’ Next Generation test demonstrates 84% sensitivity in pre-clinical testing. Performance exceeds on-market standard of FIT testing for […]